Evolution of gastritis in patients with gastric erosions

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 11, 2005, Pages 1275-1283

  Toljamo, Kari T ^a,c   Niemelä, Seppo E ^a   Karvonen, Anna Liisa ^b   Karttunen, Tuomo J ^a  

^a UNIVERSITY OF OULU   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c Salo District Hospital   (Finland)

Author keywords

Follow up; Gastric erosions; Gastritis; Helicobacter pylori; Histopathology; Parietal cell antibody

Indexed keywords

ANTIBIOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARIETAL CELL ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH EROSION;

BIOPSY, NEEDLE; CASE-CONTROL STUDIES; COHORT STUDIES; DISEASE PROGRESSION; DUODENAL ULCER; FEMALE; FINLAND; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PEPTIC ULCER; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 27844612008     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520510023594     Document Type: Article

References (35)

1. Lehmann FS, Renner EL, Meyer-Wyss B, Wilder-Smith CH, Mazzucchelli L, Ruchti C, et al. Helicobacter pylori and gastric erosions. Results of a prevalence study in asymptomatic volunteers. Digestion 2000;62:82-6.
2. Nesland AA, Berstad A. Erosive prepyloric changes in persons with and without dyspepsia. Scand J Gastroenterol 1985;20:222-8.
3. Karvonen A-L, Lehtola J. Outcome of gastric mucosal erosions. A follow-up study of elective gastroscopic patients. Scand J Gastroenterol 1984;19:228-34.
4. Karvonen AL, Sipponen P, Lehtola J, Ruokonen A. Gastric mucosal erosions. An endoscopic, histological, and functional study. Scand J Gastroenterol 1983;18:1051-6.
5. Sipponen P. Update on the pathologic approach to the diagnosis of gastritis, gastric atrophy, and Helicobacter pylori and its sequelae. J Clin Gastroenterol 2001;32:196-202.
6. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:829-32.
7. Niemelä S, Karttunen T, Kerola T. Chronic gastritis in patients with gastric ulcer; a 10-year follow-up. Scand J Gastroenterol 1995;30:428-33.
8. Maaroos H-I, Salupere V, Uibo R, Kekki M, Sipponen P. Seven-year follow-up study of chronic gastritis in gastric ulcer patients. Scand J Gastroenterol 1985;20:198-204.
9. Valle J, Kekki M, Sipponen P, Ihamäki T, Siurala M. Long-term course and consequences of Helicobacter pylori gastritis. Result of a 32-year follow-up study. Scand J Gastroenterol 1996;31:546-50.
10. Niemelä S, Karttunen T, Kerola T, Karttunen R. Ten-year follow-up study of lymphocytic gastritis: further evidence on Helicobacter pylori as a cause of lymphocytic gastritis and corpus gastritis. J Clin Pathol 1995;48:1111-6.
11. El-Omar EM, Carrington M, Chow W-H, McColl KEL, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
12. Owen RJ, Slater ER, Gibson J, Lorenz E, Tompkins DS. Effect of clarithromycin and omeprazole therapy on the diversity and stability of genotypes of Helicobacter pylori from duodenal ulcer patients. Microb Drug Resist 1999;5:141-6.
13. Stolte M, Eidt S. Chronic erosions of the antral mucosa: a sequela of Helicobacter pylori-induced gastritis. Z Gastroenterol 1992;30:846-50.
14. Roesch W, Ottenjann R. Gastric erosions. Endoscopy 1970;2:93-8.
15. Dixon MF, Genta RM, Yardley JH, Correa P, and the Participants in the International Workshop on the Histopathology of Gastritis, Houston 1994. Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 1996;20:1161-81.
16. Leung KM, Hui PK, Chan WY, Thomas TMM. Helicobacter pylori-related gastritis and gastric ulcer. A continuum of progressive epithelial degeneration. Am J Clin Pathol 1992;98:569-74.
17. Chan WY, Hui PK, Chan JKC, Cheung PSY, Ng CS, Sham CH, et al. Epithelial damage by Helicobacter pylori in gastric ulcers. Histopathology 1991;19:47-53.
18. Dixon MF, O'Connor HJ, Axon ATR, King RFJG, Johnston D. Reflux gastritis: distinct histopathological entity? J Clin Pathol 1986;39:524-30.
19. Karvonen A-L, Lehtola J. Gastric mucosal erosions; a clinical history and findings and the possible role of herpes simplex infection in aetiology. Ann Clin Res 1983;15:137-41.
20. Drossman DA, Thompson GW, Talley NJ, Funch-Jensen P, Janssens J, Whitehead WE. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterol Int 1990;4:159-72.
21. Correa P, Haenszel W, Cuello C, Zavala D, Fontham E, Zarama G, et al. Gastric precancerous process in a high risk population: Cohort follow-up. Cancer Res 1990;50:4737-40.
22. Villako K, Kekki M, Maaroos HI, Sipponen P, Uibo R, Tammur R, et al. Chronic gastritis: progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjects. Scand J Gastroenterol 1991;26 Suppl 186:135-41.
23. Kuipers EJ, Uyterlinde AM. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-8.
24. Ihamaki T, Kekki M, Sipponen P, Siurala M. The sequelae and course of chronic gastritis during a 30- to 34-year bioptic follow-up study. Scand J Gastroenterol 1985;20:485-91.
25. Toljamo K, Niemelä S, Karttunen T, Karvonen A-L, Lehtola J. Outcome of gastric mucosal erosions. Gastroenterology 2002;122 Suppl 4:A210.
26. Nomura AMY, Pérez-Pérez GI, Lee J, Stemmermann G, Blazer MJ. Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease. Am J Epidemiol 2002;1055:1054-9.
27. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-5.
28. Garcia-Gonzalez MA, Lanas A, Santolaria S, Crusius JBA, Serrano MT, Pena AS. The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer. Clin Exp Immunol 2001;125:368-75.
29. Koivurova O-P, Karhukorpi JMJ, Joensuu ET, Koistinen PO, Valtonen JM, Karttunen TJ, et al. IL-1 RN 2/2 genotype and simultaneous carriage of genotypes IL-1 RN 2/2 and IL-1beta-511 T/T associated with oesophagitis in Helicobacter pylori-negative patients. Scand J Gastroenterol 2003;38:1217-22.
30. Toljamo KT, Niemelä SE, Karttunen TJ, Karttunen RA, Karvonen A-L, Piiparinen H, et al. The role of herpes simplex and Helicobacter pylori infection in the etiology of persistent or recurrent gastric erosions. A follow-up study. Dig Dis Sci 2002;47:818-22.
31. Lehtola J, Karvonen A-L, Karttunen T, Niemelä S. Association of Campylobacter pylori with gastric erosions. Gastroenterol Int 1988;1 Suppl 1:Abst 1032.
32. O'Laughin JC, Hoftiezer JW, Ivey KJ. Effect of aspirin on human stomach in normals. Endoscopic comparison of damage produced one hour, 24 hours and 2 weeks after administration. Scand J Gastroenterol 1981;16 Suppl 67:211-4.
33. Bernersen B, Johnsen R, Straume B, Burhol PG. Erosive prepyloric changes in dyspeptics and non-dyspeptics in a defined population. The Sørreisa gastrointestinal disorder study. Scand J Gastroenterol 1992;27:233-7.
34. Karvonen AL, Kekki M, Lehtola J, Sipponen P, Ihamäki T. Prepyloric erosions: an entity of its own among erosive gastric lesions. A morphologic and dynamic study of gastric mucosa in patients with gastric erosions. Scand J Gastroenterol 1987;22:1095-101.
35. Miyake K, Tsukui T, Futagami S, Tatsuguchi A, Shinoki K, Hiratsuka T, et al. Effect of acid suppression therapy on development of gastric erosions after cure of Helicobacter pylori infection. Aliment Pharmacol Ther 2002;16 Suppl 2:210-6.